Services of MTRC

08

Oct 2018

MTRC expands the coverage of EU countries with its core service of reimbursement analysis (procedure coding, payment model, reimbursement tariffs). Work is done by MTRC personnel, supported by local reimbursement experts. Contact us, if you want to learn more. Read more

04

Oct 2018

The article "Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model", published in Plos One presented the cost effectiveness of tissue engineered bovine tissue pericardium scaffold (CardioCel) for the repair of congenital heart defects in comparison with surgery using xenogeneic, autologous, and synthetic patches over a 40-year time horizon from the perspective of the UK National Health Service. Read more

09

Sep 2018

MTRC performs the analysis using administrative databases. Reporting of procedure volume is done according to the established procedural classifications (e.g., OPCS in England, OPS in Germany). Data are available for Austria, Belgium, England, France, Germany, the Netherlands, Sweden, and Switzerland. In other countries, it might be possible to obtain data from patient registries or clinical societies. Read more

10

Aug 2018

An article “An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany” was published in the BMC Cardiovascular Disorders. The study concluded that Baroreflex activation therapy (BAT) using the Barostim neo™ device (CVRx Inc., Minneapolis, MN, USA) compared with optimized medical management in patients with advanced chronic heart failure (NYHA class III) who were not eligible for treatment with cardiac resynchronization therapy, can be cost-effective from a statutory health insurance perspective in Germany over a lifetime horizon. The ICER was €27,951/QALY (95% CI €21,357–82,970). Read more

25

Jun 2018

MTRC has developed reimbursement overviews for 14 EU countries. Overviews cover stakeholders, money flow, payment model, DRG system, innovation funding, coverage with evidence development, the role of health technology assessment, funding frameworks and reimbursement pathways. Reports are delivered in PowerPoint. Video explanations are available as well. Read more

04

Jun 2018

Report includes analysis for the following procedures: radiofrequency ablation, endoscopic plication and suturing, injection of bulking agents and endoscopic augmentation of the lower esophageal sphincter using hydrogel implants. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. Read more

04

Jun 2018

Report includes analysis for the following procedures: surgical clipping, endovascular placement of a flow diversion device, endovascular coiling and stent-assisted coiling. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. Read more

01

Jun 2018

European Med Tech and IVD Reimbursement Consulting Ltd. released a report, which identifies and provides an overview of the innovative payment schemes for medical devices and in-vitro diagnostic tests in European countries. The report was supported by the grant from the Med Tech Europe. Access the full version of the report at our web-site. Read more

25

Apr 2018

In April 2018, Oleg Borisenko with support from the MTRC launched an international stipend and mentoring program. The objective of the program is to support medical students in developing countries with achieving maximum results in a medical profession. For the first round of the program (six months until Oct 2018), three students were selected. The program includes a stipend, bi-weekly meetings on different subjects (goal setting, evidence-based medicine, clinical epidemiology, medical experiment, marketing, publication standards and others) and a personal mentoring of Oleg Borisenko. Read more

19

Apr 2018

The CEO of MTRC co-authored the article "Cost–utility analysis of bariatric surgery", published in the leading European surgical journal, British Journal of Surgery. Analysis indicated that currently used surgical methods in England were found to be cost saving over the lifetime of individuals treated in England. Read more

17

Jan 2018

Article “Cost-effectiveness analysis of bariatric surgery for morbid obesity in Belgium” published in the “Journal of Medical Economics” provides insights about economic outcomes of bariatric surgery in Belgium using Markov modeling. Over the 10-year horizon, bariatric surgery led to a cost increment of €3,788 and 1.4 additional QALY (€2,809/QALY) compared with optimal medical management. Over lifetime horizon, surgery led to 1.1 life years and 5.0 QALY gains and €9,332/patient average cost savings. Read more

04

Dec 2017

CEO of the MTRC, Dr. Oleg Borisenko will attend the "MedTech Access Leaders Forum" 5-7 of December in Berlin. Please, write to info@mtrconsult.com if you would be interested to arrange a meeting to discuss your market access needs in Europe.  Read more